MOLECULIN BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On January 11, 2021, Moleculin Biotech, Inc. (the "Company") is using the attached presentation for corporate presentations and is set forth as Exhibit 99.1 herein. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended ("Securities Act"), unless specifically identified therein as being incorporated by reference.

Item 9.01 Financial Statements and Exhibits.

(d)   Exhibits.

Exhibit No. Description

99.1 Investor Presentation dated January 2021

104 Cover page Interactive Data File (embedded within the Inline XBRL

document)

© Edgar Online, source Glimpses